Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Timothy P. Walbert Joins Sucampo's Board of Directors
October 13, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Timothy P. Walbert has joined Sucampo's...
Sucampo Launches Tender Offer to Acquire R-Tech Ueno
August 26, 2015 06:17 ET
|
Sucampo Pharmaceuticals Inc
Acquisition Expected to be Immediately Accretive
Advances Sucampo Strategy to Strengthen Financial Performance and Diversify Pipeline
Acquisition Expected to Close in Q4 2015
Company to Host...
Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update
August 05, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
Year-over-Year Earnings Growth of 495% and EPS Growth of 425%
Year-over-Year Revenue Growth of 45%
Company Increases 2015 Earnings Guidance
Company to Host Conference Call Today at 8:30 a.m....
Sucampo Announces Second Quarter 2015 Earnings Call
July 22, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2015...
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference
July 01, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 1, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)
June 15, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the China Food and Drug Administration...
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference
May 27, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 27, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
May 15, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference
May 13, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R) (lubiprostone) in China
May 11, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that it entered into an exclusive license,...